A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight

Clinical trial NCT05996848 · COMPLETED

Trial details

NCT number: NCT05996848
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity or Overweight

Start date: 2023-08-15
Primary completion: 2025-01-06
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.